Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02512029

18F-AV-1451 PET Imaging in TBI

18F-AV-1451 PET Imaging in Subjects With Subacute Traumatic Brain Injury

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Avid Radiopharmaceuticals · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study will evaluate imaging characteristics of 18F-AV-1451 in subjects with subacute traumatic brain injury.

Conditions

Interventions

TypeNameDescription
DRUG18F-AV-1451

Timeline

Start date
2015-10-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2015-07-30
Last updated
2016-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02512029. Inclusion in this directory is not an endorsement.